Transgenomic Leukodystrophy Panel

Transgenomics has launched the Leukodystrophy NGS Panel, which is designed to diagnose individuals with any of the roughly 40 inherited nervous system disorders that comprise the disease. The panel includes 137 genes, including all of those recommended under the Global Leukodystrophy Initiative's diagnostic guidelines.